This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Northwest University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Sha Liao in Health Products
Introduction
Sha Liao is an accomplished inventor based in Shaanxi, China. He has made significant contributions to the field of health products, particularly in the prevention and treatment of coronary atherosclerosis disease. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Sha Liao holds a patent for the "Use of IDHP in preparation of drug or health product for prevention and treatment of coronary atherosclerosis disease." This patent focuses on the use of isopropyl β-(3,4-dihydroxyphenyl)-α-hydroxypropionate (IDHP) in creating drugs or health products aimed at preventing and treating coronary atherosclerosis diseases. The IDHP compound is also noted for its ability to inhibit platelet aggregation, promote angiogenesis, and prepare products for the prevention and treatment of senile vascular dementia. He has 1 patent to his name.
Career Highlights
Sha Liao is affiliated with Northwest University, where he continues to engage in research and development in the health sector. His work is characterized by a commitment to improving health outcomes through innovative solutions.
Collaborations
Sha Liao collaborates with notable colleagues, including Xiaohui Zheng and Yajun Bai, who contribute to his research endeavors.
Conclusion
Sha Liao's innovative work in health products demonstrates the potential of scientific research to address significant health challenges. His contributions are paving the way for advancements in the prevention and treatment of critical diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
